Pharma-Bio Serv, Inc. (PBSV)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 10-31. Amounts in USD.

Revenue TTM

0 4M 8M 12M Q3 '24: 10.8M Q4 '24: 9.5M Q1 '25: 9.6M Q2 '25: 9.6M Q3 '25: 9.2M Q4 '25: 9M Q1 '26: 8.8M Q2 '26: 9.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 1.5M 3M 4.5M Q3 '24: 2.7M Q4 '24: 2.5M Q1 '25: 2.7M Q2 '25: 2.9M Q3 '25: 2.9M Q4 '25: 2.9M Q1 '26: 2.9M Q2 '26: 2.9M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income TTM

-1.5M -1M -500K 0 500K 1M 1.5M Q3 '24: -1.2M Q4 '24: -1.3M Q1 '25: -941.5K Q2 '25: -726.4K Q3 '25: -658.5K Q4 '25: -637.7K Q1 '26: -640K Q2 '26: -397K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-900K -600K -300K 0 300K 600K 900K Q3 '24: -840.9K Q4 '24: -777.6K Q1 '25: -498.4K Q2 '25: -189.2K Q3 '25: -84.2K Q4 '25: -100.5K Q1 '26: -76.1K Q2 '26: 61.5K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 3M 6M 9M Q3 '24: 8.1M Q4 '24: 7M Q1 '25: 6.9M Q2 '25: 6.7M Q3 '25: 6.3M Q4 '25: 6.1M Q1 '26: 6M Q2 '26: 6.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q3 '24: -336.7K Q4 '24: -566.7K Q1 '25: -1.7M Q2 '25: -1.3M Q3 '25: -416.1K Q4 '25: -214.9K Q1 '26: -175.5K Q2 '26: -239.3K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-2.1M -1.4M -700K 0 700K 1.4M 2.1M Q3 '24: -337.8K Q4 '24: -726.4K Q1 '25: -1.9M Q2 '25: -1.5M Q3 '25: -579.4K Q4 '25: -221.5K Q1 '26: -184.6K Q2 '26: -246.4K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 8M 16M 24M Q1 '24: 23M Q2 '24: 23M Q3 '24: 23M Q1 '25: 23M Q2 '25: 22.9M Q3 '25: 22.9M Q1 '26: 22.9M Q2 '26: 22.9M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.18 -0.12 -0.06 0.00 0.06 0.12 0.18 Q4 '17: -0.06 Q1 '18: -0.16 Q2 '18: -0.15 Q3 '18: -0.11 Q4 '24: -0.08 Q1 '25: -0.06 Q2 '25: -0.05 Q3 '25: -0.06 Q4 '17 Q1 '18 Q2 '18 Q3 '18 Q4 '24 Q1 '25 Q2 '25 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.